{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:35:59Z","timestamp":1791653759929,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.antiviral.2019.104597","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:43:28Z","timestamp":1567683808000},"page":"104597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"special_numbering":"C","title":["The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection"],"prefix":"10.1016","volume":"171","author":[{"given":"George R.","family":"Painter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Bluemling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"DeBergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindhya","family":"Edpuganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar R.","family":"Gruddanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien L.","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Natchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary M.","family":"Sticher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Kolykhalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.antiviral.2019.104597_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104597_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"issue":"2292","key":"10.1016\/j.antiviral.2019.104597_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.88.2292.530.a","article-title":"VENEZUELAN equine encephalomyelitis","volume":"88","author":"Beck","year":"1938","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2019.104597_bib4","first-page":"12313","article-title":"Nucleoside transporters of mammalian cells","author":"Cass","year":"1999","journal-title":"Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.antiviral.2019.104597_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3851\/IMP2229","article-title":"Antiviral activity of nucleoside analogues against norovirus","volume":"17","author":"Costantini","year":"2012","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104597_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104597_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(25)32802-8","article-title":"The disposition of acyclovir in different species","volume":"219","author":"de Miranda","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104597_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of beta-d-N(4)-hydroxycytidine as a novel inhibitor of chikungunya virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.antiviral.2019.104597_bib9","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104597_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/viro.1995.1022","article-title":"Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins","volume":"206","author":"Grieder","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104597_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2011.03.016","article-title":"Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection","volume":"414","author":"Hunt","year":"2011","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.antiviral.2019.104597_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1135\/cccc20061099","article-title":"New N4-hydroxycytidine derivatives: synthesis and antiviral activity","volume":"71","author":"Ivanov","year":"2006","journal-title":"Collect. Czechoslov. Chem. Commun."},{"issue":"11","key":"10.1016\/j.antiviral.2019.104597_bib13","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1021\/tx300298m","article-title":"The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues","volume":"25","author":"Krompholz","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"6005","key":"10.1016\/j.antiviral.2019.104597_bib14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/313762a0","article-title":"Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP","volume":"313","author":"Ollis","year":"1985","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104597_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00775-014-1216-4","article-title":"The mammalian molybdenum enzymes of mARC","volume":"20","author":"Ott","year":"2015","journal-title":"J. Biol. Inorg. Chem. : JBIC Publ. Soc. Biol. Inorg. Chem."},{"key":"10.1016\/j.antiviral.2019.104597_bib16","author":"Painter"},{"key":"10.1016\/j.antiviral.2019.104597_bib17","series-title":"N4-Hydroxycytidine and Derivatives and Anti-viral Uses Related Thereto","author":"Painter","year":"2016"},{"issue":"8","key":"10.1016\/j.antiviral.2019.104597_bib18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104597_bib19","series-title":"Biodefense: Research Methodology and Animal Models","first-page":"255","article-title":"Alphaviruses","author":"Pratt","year":"2012"},{"issue":"22","key":"10.1016\/j.antiviral.2019.104597_bib20","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1021\/jm301176r","article-title":"Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist","volume":"55","author":"Purohit","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.antiviral.2019.104597_bib21","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104597_bib22","first-page":"413","article-title":"Alphavirus antiviral drug development: scientific gap analysis and prospective research areas","volume":"7","author":"Reichert","year":"2009","journal-title":"Biosecur. Bioterrorism Biodefense Strategy, Pract. Sci."},{"issue":"12","key":"10.1016\/j.antiviral.2019.104597_bib23","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.3390\/v7122934","article-title":"Identification of a New ribonucleoside inhibitor of ebola virus replication","volume":"7","author":"Reynard","year":"2015","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.antiviral.2019.104597_bib24","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/BF01323243","article-title":"Spread of Venezuelan equine encephalitis virus in mice olfactory tract","volume":"140","author":"Ryzhikov","year":"1995","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104597_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1134\/S0006297913030036","article-title":"Structural organization of viral RNA-dependent RNA polymerases","volume":"78","author":"Shatskaya","year":"2013","journal-title":"Biochem. Biokhimiia"},{"key":"10.1016\/j.antiviral.2019.104597_bib26","series-title":"Textbooks of Military Medicine\u2014Medical Aspects of Biological Warfare","first-page":"241","article-title":"Alphavirus encephalitides","author":"Steele","year":"2007"},{"issue":"5","key":"10.1016\/j.antiviral.2019.104597_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0300985810372508","article-title":"Review paper: pathology of animal models of alphavirus encephalitis","volume":"47","author":"Steele","year":"2010","journal-title":"Vet. Pathol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104597_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1128\/AAC.47.1.244-254.2003","article-title":"Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture","volume":"47","author":"Stuyver","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2019.104597_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","article-title":"Transporter-mediated permeation of drugs across the blood-brain barrier","volume":"89","author":"Tamai","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.antiviral.2019.104597_bib30","series-title":"Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats","author":"Torrence","year":"2005"},{"key":"10.1016\/j.antiviral.2019.104597_bib31","article-title":"beta-D-N(4)-hydroxycytidine is a potent anti-alphavirus compound that induces high level of mutations in viral genome","author":"Urakova","year":"2017","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.104597_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00705-001-0773-3","article-title":"Composition of alphavirus-like replication complexes: involvement of virus and host encoded proteins","volume":"147","author":"van der Heijden","year":"2002","journal-title":"Arch. Virol."},{"issue":"36","key":"10.1016\/j.antiviral.2019.104597_bib33","doi-asserted-by":"crossref","first-page":"19419","DOI":"10.1016\/S0021-9258(19)77649-2","article-title":"Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Two transport systems with differing substrate specificities","volume":"263","author":"Vijayalakshmi","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104597_bib34","first-page":"164","article-title":"Venezuelan equine encephalitis in BALB\/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation","volume":"120","author":"Vogel","year":"1996","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.antiviral.2019.104597_bib35","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","author":"Weaver","year":"2004","journal-title":"Ann. Rev. Entomol."},{"issue":"9025","key":"10.1016\/j.antiviral.2019.104597_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(96)02275-1","article-title":"Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group","volume":"348","author":"Weaver","year":"1996","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.antiviral.2019.104597_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00766-18","article-title":"Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses","volume":"62","author":"Yoon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3\u20134","key":"10.1016\/j.antiviral.2019.104597_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:24Z","timestamp":1759062564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"alternative-id":["S0166354219302748"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104597","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104597"}}